Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Epidemiology / Chronic disease, cancer, and maternal and child health

Cancer epidemiology

13 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Define cancer incidence, mortality, survival and the mortality-to-incidence ratio

  • Explain the role of cancer registries and what they can and cannot tell us

  • Describe the major preventable causes and the cancers of importance in Uganda

Cancer is not one disease but hundreds, each with its own causes, natural history and treatment. Epidemiology describes how many people are affected, who, where and why, and tells us which cancers can be prevented or detected early.

Core measures

  • Incidence: new cases per 100,000 per year, usually age-standardised (ASR) to compare populations.
  • Mortality: deaths per 100,000 per year.
  • Prevalence: people alive with a past cancer diagnosis (survivors), important for planning services.
  • Survival: the proportion alive at 1, 3 or 5 years after diagnosis. Net survival removes deaths from other causes and is used to compare countries.
  • Mortality-to-incidence ratio (M:I): deaths ÷ new cases in the same year; a crude marker of survival where registry survival data are missing. A ratio near 0.2 suggests high survival (many cancers in high-income countries); 0.5 or more suggests poor survival.

Cancer registries

Hospital-based registry

Records patients at one hospital; good for clinical care, but cannot give population rates.

Population-based registry

Records all new cases in a defined geographic population; gives true incidence rates. In Uganda the Kampala Cancer Registry, established in 1951, is one of the oldest in Africa.

Data sources

Pathology laboratories, hospitals, death certificates, with active case-finding.

Quality indicators

Completeness, percentage microscopically verified, percentage 'death certificate only', and timeliness.

Causes and prevention

An estimated 30 to 50% of cancers are preventable by avoiding risk factors and applying existing evidence. Infection-related cancers make up a higher share in Africa than in high-income regions.

CauseExamplesPrevention
TobaccoLung, mouth, bladderTaxes, bans, cessation support
InfectionsHPV (cervical), hepatitis B and C (liver), H. pylori (stomach), HIV with HHV-8 (Kaposi sarcoma), EBV (Burkitt lymphoma)HPV and hepatitis B vaccination, treatment, safe injections
AlcoholLiver, oesophagus, breastRegulation
Diet and obesityColorectal, breast, endometrialHealthy diet, activity
Occupation and environmentAsbestos, aflatoxin, air pollutionRegulation, food safety
Ultraviolet radiationSkin cancers (high risk in people with albinism)Sun protection

In Uganda, commonly diagnosed cancers include cervical cancer, Kaposi sarcoma, breast, prostate, oesophageal and liver cancers and non-Hodgkin lymphoma. Late presentation is a major reason for poor survival: many patients arrive at advanced stage because of costs, distance and limited diagnostic and treatment capacity.

Why survival comparisons need care

A study finds five-year survival from breast cancer is 90% in one country and 50% in another. Differences can reflect:

  • Stage at diagnosis (earlier, more curable cancers in the first country).
  • Treatment access (surgery, radiotherapy, systemic therapy).
  • Lead-time bias and overdiagnosis if screening is common in the first country.
  • Completeness of follow-up: if patients are lost, deaths are missed and survival overestimated.
  • Registry quality and different definitions.

Stage-specific and age-standardised net survival are the fair comparison.

Primary preventionSecondary preventionTreatment and palliationHPV vaccine at ages 9 to14Hepatitis B vaccine atbirthTobacco controlHealthy dietCervical: HPV test, VIABreast: clinical exam,mammography where feasibleColorectal: stool tests,colonoscopySurgery, radiotherapy,systemic therapyEssential medicinesPalliative care andmorphine access
Control of cancer combines prevention, early detection and treatment.

The cancer 'elimination' idea

The WHO has launched a global strategy to eliminate cervical cancer as a public health problem: 90% of girls fully vaccinated against HPV by age 15, 70% of women screened with a high-performance test at 35 and again at 45, and 90% of women with cervical disease treated. A well-defined target plus a monitored cascade is the epidemiological approach to control.

Avoid these traps

Comparing crude rates between countries with different age structures; using hospital data as if population-based; reading rising incidence as 'more cancer' when it may reflect better detection; interpreting mortality rates as cancer risk when treatment differs.

Summary

  • Use age-standardised incidence and mortality, plus net survival, for comparisons.

  • Population-based registries give true incidence; hospital registries do not.

  • M:I ratio is a crude indicator of survival.

  • Many cancers in Africa are infection-related and preventable by vaccination and treatment.

  • Survival differences reflect stage, treatment access, lead time and data quality.

Check your understanding

Question 1
1

Which registry type can give population incidence rates?

Question 2
2

A mortality-to-incidence ratio of 0.8 suggests:

Question 3
3

HPV vaccination prevents mainly:

Question 4
4

Why do we age-standardise cancer rates?

Question 5
5

Hepatitis B vaccine is an example of:

Question 6
6

Five-year survival appears higher in a country with intensive screening partly because of:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Non-communicable diseases and their risk factorsMaternal, newborn and child health and nutrition